Adding estrogen to progesterone in luteal phase support in In Vitro Fertilization EmbryoTransfer cycles produce pregnancies with higher quantitative (βhCG) .Fertility and Sterility 2005; 84: A15- A64 .Alsian A, Kadoch I, Phillips S, Lapensee L, Hemmings R, Bissonnette F. Adding estrogen to ...
Current clinical management of breast cancer relies on clinicopathological features as well as expression of biological markers such as estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2) [1,2]. While tamoxifen has been shown to be highly effective for ...
Neoadjuvant therapyPathological complete responsePROGESTERONE-RECEPTOROPEN-LABELTRASTUZUMABEXPRESSIONESTROGENASSOCIATIONBackgroundAlthough neoadjuvant trastuzumab and pertuzumab (HP)-based regimens are recommended for human epidermal receptor-positive (HER2 +)/lymph node-positive (N +) breast cancer (BC) patients ...
Conclusion: Addition of zoledronic acid to neoadjuvant Anastrozole therapy in ER-+ve, PR-+ve, Her-2- negative, locally advanced breast cancer is effective, well tolerated and a logical alternative to chemotherapy with more concentric tumor shrinkage in elderly breast cancer patients and may ...